We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05394805
Brief Title: A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

First Submitted : May 25, 2022
First Submitted that Met QC Criteria : May 25, 2022
First Posted : May 27, 2022

Last Update Submitted that Met QC Criteria : February 27, 2023
Last Update Posted : March 1, 2023